Pay in 4 interest-free payments of $28.50 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
NVP-ADW742 was found to suppresse survival and resistance to chemotherapy in acute myeloid leukemia cells
SM16 inhibits TGFβ-induced plasminogen activator inhibitor-luciferase activity (IC50=64 nM) and TGFβ- or activin-induced Smad2 phosphorylation at concentrations between 100 and 620 nM
3-dihydro-1H-benzo[d]imidazol-5-yl)-3
NB-598 suppresses triglyceride biosynthesis through the farnesol pathway
it was also found that LCZ696 could inhibit cardiac hypertrophy
(S)-Willardiine Catalog No.:M8448-2 NVP-ADW742 was found to suppresse(S) Willardiine is a potent agonist of AMPA kainate receptors with EC50 of 44. 8 uM. IC50 value: 44. 8 uM(EC50) Target: AMPA kainate receptor agonistin vitro: The (S) but not (R) isomers of willardiine and 5 bromowillardiine were potent agonists, producing rapidly but incompletely desensitizing responses . At a concentration of 1. 8 mM, Ca2+ inhibited the currents induced by 100 microM willardiine by approximately 50% . in vivo: In newborn mice (P5,
US$ 45.00
US$ 115.00
US$ 75.00
US$ 125.00
US$ 163.00
US$ 157.00